QuidelOrtho
QDEL
#3588
Rank
$2.86 B
Marketcap
$42.82
Share price
-2.66%
Change (1 day)
-51.03%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

P/S ratio for QuidelOrtho (QDEL)

P/S ratio as of May 2024 (TTM): 0.9566

According to QuidelOrtho's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.956612. At the end of 2023 the company had a P/S ratio of 1.64.

P/S ratio history for QuidelOrtho from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20231.64-5.18%
20221.73-47.71%
20213.31-27.16%
20204.55-22.56%
20195.8759.52%
20183.68-30.62%
20175.3145.4%
20163.651.32%
20153.60-33.82%
20145.44-9.29%
20136.0049.63%
20124.0126.43%
20113.17-12.75%
20103.6449.31%
20092.43-26.67%
20083.32-38.44%
20075.3925.21%
20064.318.99%
20053.9589.8%
20042.08-39.52%
20033.44162.06%
20021.31-56.4%
20013.01

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.30 454.27%๐Ÿ‡บ๐Ÿ‡ธ USA
3.50 266.25%๐Ÿ‡บ๐Ÿ‡ธ USA
8.74 813.91%๐Ÿ‡บ๐Ÿ‡ธ USA
4.31 350.09%๐Ÿ‡บ๐Ÿ‡ธ USA
0.8974-6.19%๐Ÿ‡บ๐Ÿ‡ธ USA
4.47 367.35%๐Ÿ‡บ๐Ÿ‡ธ USA